dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Sever, Mehmet Şükrü |
dc.contributor.author | Jager, Kitty J. |
dc.contributor.author | Vanholder, Raymond |
dc.contributor.author | Stengel, Benedicte |
dc.contributor.author | Harambat, Jerome |
dc.contributor.author | Finne, Patrik |
dc.contributor.author | Soler Romeo, Maria Jose |
dc.date.accessioned | 2022-03-11T13:48:32Z |
dc.date.available | 2022-03-11T13:48:32Z |
dc.date.copyright | 2020 |
dc.date.issued | 2021-01 |
dc.identifier.citation | Sever MŞ, Jager KJ, Vanholder R, Stengel B, Harambat J, Finne P, et al. A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community. Clin Kidney J. 2021 Jan;14(1):23–35. |
dc.identifier.issn | 2048-8513 |
dc.identifier.uri | https://hdl.handle.net/11351/7150 |
dc.description | Insuficiència renal crònica; Diàlisi; Trasplantament de ronyó |
dc.description.sponsorship | The treatment of kidney failure is costly, therefore financial support from governments is essential to ensure that all patients receive appropriate treatment. This imposes a major burden on the economy. According to the World Bank, only 74% of governments in Eastern and Central Europe provide full support for KRT [7]. Funding of treatment in earlier stages of CKD is even more problematic because of the high number of patients and because the diagnosis may not be made in a timely manner. Although no objective data are available, it is very likely that public funding at earlier stages of CKD is less common or, at least, less comprehensive than reimbursement of KRT. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Clinical Kidney Journal;14(1) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Insuficiència renal crònica - Tractament |
dc.subject | Insuficiència renal crònica - Prevenció |
dc.subject | Medicina - Investigació |
dc.subject.mesh | Kidney Failure, Chronic |
dc.subject.mesh | /therapy |
dc.subject.mesh | Research Design |
dc.title | A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/ckj/sfaa218 |
dc.subject.decs | fallo renal crónico |
dc.subject.decs | /terapia |
dc.subject.decs | diseño de la investigación |
dc.relation.publishversion | https://doi.org/10.1093/ckj/sfaa218 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sever MŞ] Department of Nephrology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. [Jager KJ] ERA-EDTA Registry, Department of Medical Informatics, Amsterdam Public Health Research Institute Amsterdam, Noord-Holland, The Netherlands. [Vanholder R] Nephrology Section, Department of Internal Medicine and Pediatrics, University Hospital Ghent, Gent, Belgium. European Kidney Health Alliance (EKHA), Brussels, Belgium. [Stengel B] UVSQ, University Paris-Saclay, University Paris-Sud, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France. [Harambat J] UVSQ, University Paris-Saclay, University Paris-Sud, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France. Pediatric Nephrology Unit, Bordeaux University Hospital, Bordeaux, France. [Finne P] Helsinki University Central Hospital, Division of Nephrology, Helsinki, 00029, Finland. [Soler MJ] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33570513 |
dc.identifier.wos | 000642311200006 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |